Asparagus racemosus
Best for
Ease the full menopause symptom load
Barely detectable · 250 mg/day for 24 weeks · 1 study , n=40
1 papers · 1 claim · 7 outcomes scored · 1 positive
Outcomes
What asparagus racemosus actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Outcome Effect size Evidence Dose Weeks Rank
Ease the full menopause symptom load Barely detectable
Less joint pain, fewer palpitations, and cooler nights.
1 RCT n=40 250 mg 24 wk
1 RCT
n=40
250 mg
24 wk
—
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Ease the full menopause symptom load Barely detectable | | 1 RCT n=40 | 250 mg | 24 wk | — |
Risk profile
Adverse events and known drug interactions
Safety events
adrenal_insufficiency / HPA axis suppression severe
Cushingoid features (facial puffiness) moderate
weight_gain moderate
new-onset diabetes mellitus (HbA1c 6.5%) moderate
gastrointestinal_disturbance mild
subclinical_hypothyroidism (TSH 7.19 µIU/mL, anti-TPO positive) mild
Related